March 23, 2009

AMGEN INC: Ariad’s Appeal to Breach Ruling Not Yet Set for Trial

COMPANIES: Amgen Inc | Ariad Pharmaceuticals Inc
Subscribe

Oral argument on Ariad Pharmaceuticals Inc.’s appeal from the U.S. District Court for the District of Delaware’s patent infringement ruling in favor of Amgen Inc. remains to be scheduled.

On April…

TO CONTINUE READING,LOGIN or
TOPICS: Drugs/Pharmaceuticals | Legal Issues, Litigation | Patents, Intellectual Prop. | SEC-Qtrly, Annual Reports | Securities & Exch Comm, US
LOCATIONS: California | Delaware | United States